Forsyth Institute, 245 First Street, Cambridge, MA 02132, USA.
Mol Aspects Med. 2017 Dec;58:21-36. doi: 10.1016/j.mam.2017.04.006. Epub 2017 May 18.
Periodontitis is an inflammatory disease of the supporting structures of the dentition that is initiated by bacteria that form a biofilm on the surface of the teeth. The pathogenesis of the disease is a result of complex interactions between the biofilm and the host response that results in dysbiosis of the microbiome and dysregulation of the inflammatory response. Current data suggest that the excess inflammation associated with periodontitis is due to a failure of resolution of inflammation pathways. In this review, the relationship between inflammation and microbial dysbiosis is examined in the context of pro-inflammation and pro-resolution mediators and their ability to modify the course of disease. The impact of local oral inflammation on systemic inflammation and the relationship of periodontitis to other inflammatory diseases, including type 2 diabetes and cardiovascular disease is reviewed. Active resolvers of inflammation, including the lipoxins and resolvins, show great promise as therapeutics for the treatment of periodontitis and other inflammatory diseases.
牙周炎是一种由牙齿表面细菌生物膜引发的牙齿支持结构的炎症性疾病。该疾病的发病机制是生物膜与宿主反应之间复杂相互作用的结果,导致微生物组的失调和炎症反应的失调。目前的数据表明,与牙周炎相关的过度炎症是由于炎症途径的解决失败。在这篇综述中,我们在促炎和促解决介质的背景下检查了炎症与微生物失调之间的关系,以及它们改变疾病进程的能力。我们还回顾了局部口腔炎症对全身炎症的影响,以及牙周炎与其他炎症性疾病(包括 2 型糖尿病和心血管疾病)的关系。炎症的积极解决者,包括脂氧素和 resolvins,作为治疗牙周炎和其他炎症性疾病的治疗方法显示出巨大的希望。